Eric B. Gordon Founder, CEO and Chairman
Mr. Gordon has a successful track record of identifying and bringing emerging medical and healthcare technologies into the clinic, industry and major market dominance. Over 30+ years, he has initiated, driven and managed through full development and/or full global commercialization seven startup companies in pediatric, adult and traveler's vaccines (Connaught Labs -now Sanofi-Pasteur, and Virogenetics); in combinatorial chemistry for drug discovery (ArQule); in clinical genomics (Ardais); in drug-delivery for endometriosis (Combinent); in HDL/CHD therapeutics (Cardium); and in behavioral health/ADHD diagnostics (BioBehavioral Diagnostics).
He began his career with Arthur Andersen & Co., and served as VP and CFO at Sterling Drug. Eric holds business degrees from Syracuse University, the University of Pennsylvania, The Wharton School.
Best Experience: "In April 2014 during our Phase II Study, a father called me at home around 9:30 in the evening, “Just got home from picking up my daughter at her ballet lesson. S_____ for the first time could hold a pose for 10 seconds!!!! [in tears]” Been there myself so many times."